This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Liu, S. Articles by Jiang, S. Search for Related Content PubMed PubMed Citation Articles by Liu, S. Articles by Jiang, S. Social Bookmarking                         What's this?

Rapid and Automated Fluorescence-Linked Immunosorbent Assay for High-Throughput Screening of Hiv-1 Fusion Inhibitors Targeting gp41

sjiang{at}nybloodcenter.org

Louise Boyer-Chatenet

Hong Lu

Shibo Jiang

Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY

The human immuno deficiency virus type 1 (HIV-1) envelope glycoprotein gp41 plays animportant role in the virus entry. During the process of fusion between the viral and target cell membranes, the N-and C-terminal heptad repeat (HR) regions of the gp41 extracellular domain associate to form a 6-helical bundle, corresponding to the fusion-active gp41 core. Any compound that blocks the gp41 6-helix bundle formation between the N- and C-peptides, which are derived from the N- and C-terminal HR regions, respectively, may inhibit HIV-1 mediated membrane fusion. Based on this principle, we previously established a sandwich enzyme-linked immunosorbent assay (ELISA) for drug screening by using the N-peptide N36 and the C-peptide C34 and a monoclonal antibody (NC-1) which specifically recognizes the gp41 6-helix bundle. In the present study, a fluorescence-linked immunosorbent assay (FLISA) was developed by using fluorescein isothiocyanate (FITC)-conjugated C34 to replace C34 and by directly detecting fluorescence intensity instead of more complicated enzymatic reaction. Compared with the sandwich ELISA, this FLISA has similar sensitivity and specificity, but it is much more rapid, economic and convenient. Using an Integrated Robotic Sample Processing System, this assay has been applied for high-throughput screening of organic compounds on a large scale for HIV-1 fusion inhibitors targeting gp41.

Key Words: FLISA • HTS • HIV-1 • fusion inhibitors • gp41

Journal of Biomolecular Screening, Vol. 8, No. 6, 685-693 (2003)
DOI: 10.1177/1087057103259155


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Wang, Z. Qi, A. Guo, Q. Mao, H. Lu, X. An, C. Xia, X. Li, A. K. Debnath, S. Wu, et al. ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation Antimicrob. Agents Chemother., December 1, 2009; 53(12): 4987 - 4998. [Abstract] [Full Text] [PDF]

				L. Cai and M. Gochin A Novel Fluorescence Intensity Screening Assay Identifies New Low-Molecular-Weight Inhibitors of the gp41 Coiled-Coil Domain of Human Immunodeficiency Virus Type 1 Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2388 - 2395. [Abstract] [Full Text] [PDF]

				S. Liu, W. Jing, B. Cheung, H. Lu, J. Sun, X. Yan, J. Niu, J. Farmar, S. Wu, and S. Jiang HIV gp41 C-terminal Heptad Repeat Contains Multifunctional Domains: RELATION TO MECHANISMS OF ACTION OF ANTI-HIV PEPTIDES J. Biol. Chem., March 30, 2007; 282(13): 9612 - 9620. [Abstract] [Full Text] [PDF]

				S. Liu, H. Lu, J. Niu, Y. Xu, S. Wu, and S. Jiang Different from the HIV Fusion Inhibitor C34, the Anti-HIV Drug Fuzeon (T-20) Inhibits HIV-1 Entry by Targeting Multiple Sites in gp41 and gp120 J. Biol. Chem., March 25, 2005; 280(12): 11259 - 11273. [Abstract] [Full Text] [PDF]